New York 2025-2026 Regular Session

New York Assembly Bill A06475

Introduced

3/5/25

Refer

3/5/25

Refer

1/7/26

Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.

No companion bills found.

Require insurance coverage for certain prostate cancer screening

Insurance; annual prostate cancer screenings for certain men; require major medical coverage

Health Insurance - Genetic Testing and Cancer Imaging - Required Coverage

Enacts provisions relating to insurance coverage of genetic screenings for cancer risk

Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Biomarker Testing.

Health Insurance - Screening for Ovarian Cancer - Required Coverage and Prohibited Cost Sharing

An Act to Update the Requirements for Health Insurance Coverage of Prostate Cancer Screening

Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Biomarker Testing.

Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Biomarker Testing.

Expands requirements for health insurance carriers concerning prostate cancer screening and requires coverage be provided without cost sharing.

No similar bills found.